Cited by 10Pituitary Gland Disorders and TreatmentsStress Responses and CortisolElectrolyte and hormonal disorders

Neuropsychological functioning in patients with Cushing’s disease and Cushing’s syndrome

Siegel, Sonja, Kirstein, Cedric Fabian, Grzywotz, Agnieszka, Hütter, Bernd Otto, Wrede, Karsten Henning, Kuhna, Victoria, Kreitschmann-Andermahr, Ilonka·2021·Experimental and Clinical Endocrinology & Diabetes

Abstract

Purpose To present a systematic review of the presence and severity of neuropsychological impairment in the six main neuropsychological domains (attention, executive function, language, visuospatial processing, intelligence, and memory) in patients with Cushing’s disease (CD) and/or Cushing’s Syndrome (CS) at various stages of the illness. The work aims to identify neuropsychological leverage points for focused diagnosis and rehabilitation in CS/CD patients. Methods A pubmed literature search was performed and augmented by searching the reference lists of review articles identified by this search strategy. After excluding irrelevant hits, we systematically extracted data from 27 studies for each main neuropsychological domain, differentiating between active disease, short- and long-term remission. Results The literature gives evidence for neuropsychological impairment in all domains in Cushing patients with active disease. The most consistent impairments concerned memory and visuo-spatial processing, whereas the data are discordant for all other domains. Significant improvement of neuropsychological function – although not returning to normal in all domains – is shown in short-term and long-term remission of the disease. However, the published literature is thin, suffering from repetitive subsample analyses publishing, methodological concerns as lack of control for confounders such as depression. Conclusions Memory is the most extensively investigated domain in CS/CD patients and impairment is most prominent in active disease. Patients should be counseled that neuropsychological function will improve with normalization of hypercortisolism and over time. More studies with more stringent methodological criteria, larger patient samples and controlling for confounders are required to enhance our understanding of neuropsychological function in patients with CS/CD.

Integrity signals

Registry

Crossref · 10.1055/a-1247-4651

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Glucocorticoid therapy has been implicated in the development of white matter hyperintensities which reflect reduction of white matter structural integrity.

    “Glucocorticoid therapy has been implicated in the development of white matter hyperintensities which reflect reduction of white matter structural integrity (691).”
  • Glucocorticoid therapy in CAH has been reported to affect working memory and digit span scores; patients on higher glucocorticoid doses have worse performance.

    “Glucocorticoid therapy in CAH has been reported to affect working memory and digit span scores; patients on higher glucocorticoid doses have worse performance (691).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Siegel, S., Kirstein, C. F., Grzywotz, A., Hütter, B. O., Wrede, K. H., Kuhna, V., & Kreitschmann-Andermahr, I.
Affiliations
  • University of Duisburg-Essen (DE)
  • Carl von Ossietzky Universität Oldenburg (DE)
  • Department of Neurosurgery, University of Duisburg-Essen, Essen
Venue
Experimental and Clinical Endocrinology & Diabetes
Published
2020-09-29
Volume
129
Issue
03
Pages
194-202
ISSN
  • 0947-7349 (ISSN-L)
  • 1439-3646
OpenAlex
W3089659418
Cited by
10
References
5
Citations by year
2026: 3 · 2025: 2 · 2023: 1 · 2022: 3 · 2021: 1
FWCI
0.19
Type
journal article
Language
en
Open access
closed
Locations
  • Experimental and Clinical Endocrinology & Diabetes (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Electrolyte and hormonal disorders
Keywords
Cushing's disease, Cushing's syndrome, neuropsychological deficits, memory impairment, visuospatial processing, executive function, attention, language, intelligence, remission, hypercortisolism, depression
MeSH terms
Cushing Syndrome, Humans, Pituitary ACTH Hypersecretion, Cognitive Dysfunction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review